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ABSTRACT
Background: Polyphenols are phytochemicals that have been associated with therapeutic effects in stress-related disorders. 
Indeed, studies suggest that polyphenols exert significant neuroprotection against multiple neuronal injuries, including 
oxidative stress and neuroinflammation, but the mechanisms are unclear. Evidence indicates that polyphenol neuroprotection 
may be mediated by activation of Nrf2, a transcription factor associated with antioxidant and cell survival responses. On the 
other hand, in stress-linked disorders, Fkbp5 is a novel molecular target for treatment because of its capacity to regulate 
glucocorticoid receptor sensitivity. However, it is not clear the role Fkbp5 plays in polyphenol-mediated stress modulation. 
In this study, the neuroprotective effects and mechanisms of the naturally derived polyphenols xanthohumol and quercetin 
against cytotoxicity induced by corticosterone were investigated in primary cortical cells.
Methods: Primary cortical cells containing both neurons and astrocytes were pre-incubated with different concentrations of 
quercetin and xanthohumol to examine the neuroprotective effects of polyphenols on cell viability, morphology, and gene 
expression following corticosterone insult.
Results: Both polyphenols tested prevented the reduction of cell viability and alterations of neuronal/astrocytic numbers 
due to corticosterone exposure. Basal levels of Bdnf mRNA were also decreased after corticosterone insult; however, this was 
reversed by both polyphenol treatments. Interestingly, the Nrf2 inhibitor blocked xanthohumol but not quercetin-mediated 
neuroprotection. In contrast, we found that Fkbp5 expression is exclusively modulated by quercetin.
Conclusions: These results suggest that naturally derived polyphenols protect cortical cells against corticosterone-induced 
cytotoxicity and enhance cell survival via modulation of the Nrf2 pathway and expression of Fkbp5.
Keywords:  cortical neurons, corticosterone, polyphenols, stress
Introduction
Alterations in hypothalamic-pituitary-adrenal (HPA) axis func-
tion have been associated with many neuropsychiatric dis-
orders including depression, anxiety, anorexia nervosa, and 
posttraumatic stress disorder (de Kloet et  al., 2006; Pariante 
and Lightman, 2008). It is well known that the HPA axis is acti-
vated in response to stress, leading to increased concentration 
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of glucocorticoids in the circulation. These steroid hormones 
are critically involved in the homeostatic regulation of metab-
olism, development, and immune function (Sapolsky, 2000). 
Moreover, preclinical studies have shown that chronic exposure 
to glucocorticoids produces deleterious effects to the structure 
and functional plasticity of the hippocampus and amygdala of 
adult rats (Mitra and Sapolsky, 2008; Zhu et  al., 2013). In add-
ition, stress-induced increase of glucocorticoids has also been 
associated with impairment in the structure and function of 
the prefrontal cortex (PFC), a brain region that has been im-
plicated in executive function (Arnsten, 2009). Indeed, chronic 
stress exposure induces loss of dendrites and spines in pyram-
idal cells of the PFC in rodents, which correlates with impaired 
working memory in the delayed alternation task (Hains et al., 
2009; Shansky et al., 2009). In humans, chronic stress has been 
shown to weaken functional connectivity in the PFC and regula-
tion of the amygdala, which correlates with loss of grey matter 
(Arnsten, 2015). Moreover, brain-derived neurotrophic factor 
(BDNF), which maintains neuronal survival and plasticity, is de-
creased in chronically stressed animals and patients with major 
depressive disorder and stress-related disorders (Murakami 
et al., 2005; Brunoni et al., 2008). Based on these observations, a 
drug that can attenuate the effects of chronic exposure to gluco-
corticoids on brain function may have therapeutic potential in 
preventing and treating stress-related disorders.
Polyphenolic compounds are natural phytochemicals found 
abundantly in plant food sources and characterized by the pres-
ence of multiple hydroxyl structural units on aromatic rings 
(Vauzour, 2012). Several in vivo studies have focused on the 
potential of dietary polyphenols in protecting cognitive func-
tion and reducing risk for developing neurodegenerative and 
neuropsychiatric disorders, including depression and anxiety 
(Bhutada et  al., 2010; Hurley et  al., 2014; Lopresti et  al., 2014). 
Indeed, increasing data support the neuromodulatory potential 
of polyphenols via their ability to protect vulnerable neurons 
and improve neuronal function and regeneration (Spencer, 
2008). In particular, several in vitro studies have confirmed the 
neuroprotective capacity of polyphenols mainly against cyto-
toxicity by both oxidative stress and amyloid peptide (Aβ) neur-
onal insult (Godoy et al., 2017).
Polyphenols vary in their chemical structure and func-
tional activity (Vauzour et al., 2010). Xanthohumol, for example, 
is a prenylated chalcone isolated from the female hop plant, 
Humulus lupulus, and has been shown to possess anticancer, 
antiinflammatory, and neuroprotective effects in vitro (Liu et al., 
2015; Yao et al., 2015). On the other hand, quercetin, a member 
of the flavonoid family, is one of the most prominent and widely 
distributed polyphenols in nature and is found in many fruits, 
vegetables, leaves, and grains (Manach et  al., 2004). Quercetin 
has been associated with countless beneficial health effects 
such as protection against certain types of cancer and cardio-
vascular and neurodegenerative disorders (Boots et  al., 2008; 
Godoy et al., 2017).
It is well known that polyphenols can activate the nuclear 
factor erythroid 2-related factor-2 (Nrf2), a redox-sensitive 
transcription factor related to cell survival and antioxidant re-
sponses (Ungvari et al., 2010; Gopinath and Sudhandiran, 2012). 
On the other hand, there is evidence showing that polyphenols 
are able to modulate the glucocorticoid receptor (GR) function. 
Indeed, the polyphenolic flavonoid icariin is able to alter the 
expression of the GR and the FK506 binding protein 5 (FKBP5), 
which promotes GR stability and reduces GR sensitivity to GC 
in vivo (Wei et al., 2016). Actually, modulation of the GR regula-
tory system is currently an interesting target for treatment for 
stress-related disorders; therefore, more research is needed in 
this area (O’Leary et al., 2013).
Significance Statement
Stress-related mental disorders, including depression and anxiety, are currently a major public health concern. Thus, research 
and drug discovery focused on treatment for mental illnesses linked with stress are of substantial interest. A number of novel 
natural compounds have been associated with potential therapeutic effect for depression and anxiety. For example, naturally 
derived polyphenols have demonstrated positive effects against stress-induced mood despair; however, the mechanisms are un-
clear. On the other hand, cellular models represent a practical approach to assess gene expression and protein trafficking after 
drug exposure. In this study, we examined the protective capacity of polyphenols against chronic exposure to corticosterone 
(the main stress hormone) on cortical neurons in vitro. The results of this work provide new evidence about the neuroprotective 
properties of polyphenols and a novel insight into the potential mechanisms underlying polyphenol-mediated improvement of 
stress-related disorders.
Table 1. Real Time Polymerase Chain Reaction (PCR) Primers
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The purpose of the present study was to explore through 
an in vitro approach new pharmacological strategies to treat 
stress-related disorders. In particular, we examined whether 
xanthohumol and quercetin, two naturally derived polyphe-
nols, protect against corticosterone-induced toxicity in neurons 
derived from the brain cortex, a key brain area involved in the 
pathophysiology of stress-related disorders. In addition, we ex-
plored the molecular mechanisms potentially implicated in such 
an effect. Specifically, we examined the interaction between the 
Nrf2 pathway and the GR signaling pathway to elucidate the key 
molecular mechanisms through which polyphenols may protect 
neuronal integrity and improve stress-related disorders.
METHODS
Chemical and Reagents
Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum 
(FBS), poly-L-lysine, corticosterone (CORT), trypsin, L-glutamine, 
penicillin/streptomycin, D-glucose, 3-(4,5-Dimethyl-2-thiazolyl)-
2,5-diphenyl-2H-tetrazolium bromide (MTT), dimethyl sulfoxide, 
Triton X-100, RU486, HEPES, NaCl, trigonelline, and quercetin 
were purchased from Sigma. B-27 supplement was obtained 
from Thermo Fisher Scientific. Xanthohumol (purity 65–85%) 
was provided by Hopsteiner.
Animals
All procedures on live animals were performed under li-
cense from the Government of Ireland Department of Health 
(B100/3774) in accordance with National and European Union 
directive 2010/63/EU, with prior ethical approval by University 
College Cork (AEEC #2012/045). Experiments were conducted in 
accordance with guidelines established by University College 
Cork’s Animal Welfare Body.
Cell Culture
Primary cortical cell cultures, consisting of both neurons and 
astrocytes, were prepared as described previously (Pusceddu 
et  al., 2016) with some modifications. Briefly, post-natal day 1 
(PND1) Sprague Dawley male rats were euthanized, brains re-
moved, and cerebral cortices dissected. Tissue was enzymatically 
dissociated with trypsin (0.25 µg/mL) and then triturated using 
a glass Pasteur pipette in warm DMEM-F12 with 10% FBS and 
100  µg/mL DNase. Cell suspension was passed through 40-µm 
strainer and then centrifuged at 1000  rpm for 10 minutes at 
room temperature. The pellet was resuspended in warm cul-
ture media (DMEM-F12 supplemented with B-27, 1% FBS, 100 U/
mL penicillin, 100 µg/mL streptomycin, L-glutamine 2 mM, and 
D-glucose 55  mM). The suspended cells were cultured at 37°C 
with 5% CO2.
Cell Treatment
Quercetin and xanthohumol were selected after we detected 
their positive effects in a preliminary in vitro screen testing 
the potential of several polyphenolic compounds, including 
resveratrol, naringin, and astaxanthin, against CORT cyto-
toxicity in cortical cells (data not shown). Quercetin (0.03, 0.3, 
and 3  µM) and xanthohumol (0.2, 1, and 5  µM) were added to 
primary cortical cell cultures at day in vitro (DIV) 5 and main-
tained for 24 hours. The media was replaced with fresh media 
containing 200 µM CORT at DIV6 and kept for 96 hours (Figure 
2A). The doses of polyphenols were chosen based on previous 
publications, which showed neuroprotective effects in vitro 
(Yao et al., 2015; Godoy et al., 2017). To investigate the involve-
ment of Nrf2 signaling in quercetin and xanthohumol-mediated 
neuroprotective effects, cells were co-treated with a spe-
cific Nrf2 inhibitor (5  µM trigonelline) along with quercetin or 
xanthohumol prior to CORT treatment. The dose of trigonelline 
was based on previous studies of Nrf2 inhibition in cellular 
models (Arlt et al., 2013; Rizza et al., 2015).
Cell Viability Measurement
Cell viability was determined by an MTT assay based on mito-
chondrial dehydrogenase activity of viable cells as previously 
described (Mosmann, 1983). Briefly, cortical cells were cultured 
in a 24-well plate at a density of 4 × 104 cells per well. After treat-
ment, medium was removed and replaced with fresh culture 
medium containing MTT (500 µg/mL) and then incubated at 37°C 
for 3 hours. Afterwards, 100 µL of dimethyl sulfoxide was added 
to each well to dissolve the resulting formazan. The absorbance 
values were measured by spectrophotometry at 570  nm with 
a microplate reader (BioTek Synergy HT). The results were ex-
pressed as a percentage of vehicle control group.
LDH Release Determination
Lactate dehydrogenase (LDH) release is usually quantified as 
a marker for cell lysis and necrosis (Brito et al., 2006). LDH re-
lease  was measured using the Cytotoxicity Detection Kit LDH 
(Roche) according to the manufacturer’s instructions. Briefly, 
cortical cells were cultured in a 24-well plate at a density of 
4 × 104 cells per well. After treatment, medium was transferred 
to a 96-well plate. Mix solution from the kit containing both 
catalyst and dye solution was added to the wells and incubated 
for 30 minutes at room temperature protected from light. The 
absorbance values were measured by spectrophotometry at 
490 nm with a microplate reader (BioTek Synergy HT).
Immunocytochemistry
Cellular staining for βIII-tubulin and Glial Fibrillary Acidic 
Protein (GFAP) proteins, molecular markers for neurons and 
astrocyte, respectively, was assessed through immunofluores-
cence detection as previously described (Pusceddu et al., 2016). 
Briefly, cortical cells were fixed with ice-cold methanol for 10 
minutes and then blocked overnight in 5% horse serum at 4°C. 
Subsequently, the cells were incubated in primary antibody 
solution (mouse anti-βIII-tubulin 1:300, Promega; rabbit anti-
GFAP 1:300, Dako) overnight at 4°C. The following day, the cells 
were incubated with the appropriate secondary antibody (Alexa 
Fluor 594 donkey anti-mouse 1:2000, Thermo Fisher; Alexa Fluor 
488 donkey anti-rabbit 1:2000, Thermo Fisher) for 1 hour at room 
temperature. Finally, cellular counterstaining was assessed with 
Hoechst 33258 (Sigma) for 5 minutes. The cells were viewed 
using an Olympus BX53 upright fluorescence microscope.
Quantitative RT-PCR
Total RNA was isolated from primary cortical cells using the 
High Pure RNA isolation kit (Roche). Briefly, cells were seeded 
at a density of 1.5 × 106 cells per well in 6-well plates followed 
by pretreatments with quercetin and xanthohumol before CORT 
insult. Cells were harvested and the lysate transferred into a 
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spectrophotometer. Subsequently, isolated RNA was reverse 
transcribed into cDNA using the ExiLERATE LNA qPCR, cDNA 
synthesis kit (Exiqon). Following reverse transcription, mRNA 
expression levels of respective genes (Table 1) were measured 
using a lightcycler 480 II (Roche). Amplification was performed 
using ExiLERATE LNA qPCR, SYBR Green master mix kit (Exiqon). 
Each sample was analyzed in triplicate for both target gene and 
reference gene (β-actin), and the relative mRNA expressions 
were calculated using the 2-ΔΔCt method (Livak and Schmittgen, 
2001).
Reverse-Phase Protein Array (RPPA)
High-throughput RPPA for 249 proteins (antibody list provided 
in Supplementary Information) was performed following the 
protocol and directions of MD Anderson Center (Houston, TX), 
where RPPA was performed. Briefly, cells were seeded at a density 
of 1.5 × 106 cells per well in 6-well plates followed by pretreat-
ment with quercetin and xanthohumol before CORT insult. Cells 
were harvested and then lysed using the lysis buffer suggested 
by MD Anderson (1% Triton X-100, 50 mM HEPES, pH 7.4, 150 mM 
NaCl, 1.5 mM MgCl2, 1 mM EGTA, 100 mM NaF, 10 mM Na pyro-
phosphate, 1  mM Na3VO4, and 10% glycerol). Total protein con-
centration in lysates was determined by performing a BCA assay 
(Thermo Scientific), and samples were adjusted to a concentra-
tion of 1–1.5 μg/μL. Samples were then denatured using the so-
dium dodecyl sulfate (SDS) sample buffer recommended by the 
core facility, boiled for 5 minutes, and then stored at −80°C be-
fore being shipped to MD Anderson Center on dry ice. Samples 
were then serially diluted and arrayed onto nitrocellulose-
coated slides. Slides were then probed with the core facility’s 
collection of antibodies, and signal was generated using a 
3, 3′-diaminobenzidine colorimetric reaction-based system. 
Results provided by MD Anderson Center  were then analyzed 
using the functional annotation tool DAVID 6.8 to detect up- or 
downregulation of signaling pathways within the KEGG database.
Statistical Analysis
Statistical analysis was performed using the software SPSS 24.0, 
and the results were presented as mean ± SEM. Data were ana-
lyzed using 1- or 2-way ANOVA as appropriate. A P value of .05 
was considered statistically significant.
RESULTS
CORT-Induced Changes in Cortical Cells were 
Mediated by the GR
To investigate the role of the GR in CORT-elicited cytotoxicity in 
cortical cells, dose and time curve responses of CORT were deter-
mined by MTT assay. At DIV5 the cells were treated with CORT for 
72 and 96 hours (Figure 1A). As expected, stimulation with CORT 
caused a significant reduction in cell viability at 96 hours (Figure 
1B–C). Pre-incubation with the GR antagonist RU486 ameliorated 
the reduction of cell viability caused by CORT (Figure 1D).
Xanthohumol and Quercetin Prevented CORT-
Induced Cytotoxicity in Cortical Cells
To determine the protective effects of xanthohumol and quer-
cetin from CORT-induced cytotoxicity, cortical cells were 
Figure 1. Corticosterone (CORT)-induced cytotoxicity in cortical cells is mediated by the glucocorticoid receptor (GR). (A) Schematic representing the experiment time-
line. (B–C) Cortical cells were treated with various concentrations of CORT for 72 and 96 hours. (D) Cortical cells were pretreated with 50 nM of RU486 for 24 hours and 
then treated with 200 µM CORT for 96 hours. Cell viability was measured by 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. Results are 
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pre-incubated with different concentrations of xanthohumol 
and quercetin (Figure 2A). The reduction of cell viability in cor-
tical cells induced by 96 hours of incubation with 200 µM CORT 
was significantly prevented by 24-hour pretreatment with both 
xanthohumol (1 or 5 µM) and quercetin (3 µM) (Figure 2B–C).
Xanthohumol and Quercetin Prevented CORT-
Induced Alterations in Neuron and Astrocyte 
Proportion
To further determine the potential protective effects of 
xanthohumol and quercetin against CORT-induced cytotoxicity, 
we explored whether these polyphenols prevented the alter-
ation in neuron and astrocyte composition caused by CORT in 
cortical cells. As illustrated in Figure 2D–H, pretreatment with 
both xanthohumol and quercetin prevented the decrease in the 
number of neurons and the increase in astrocytes induced by 
treatment with 200 µM CORT.
Xanthohumol and Quercetin Prevented CORT-
Induced Apoptotic Morphological Changes in 
Cortical Cells
To define the type of cell death triggered by CORT, apoptotic and 
necrotic features were measured in cortical cells after CORT ex-
posure. Apoptosis is characterized by morphological changes 
including chromatin condensation and reduction of cell mem-
brane permeability. On the other hand, membrane integrity is 
completely lost during necrosis (Brito et al., 2006). A 24-hour pre-
incubation with 5 µM xanthohumol and 3 µM quercetin reduced 
the number of condensed nuclei in cortical cells after 200  µM 
CORT treatment for 96 hours (Figure 2I–K). Extracellular LDH ac-
tivity was not increased after CORT treatment, suggesting that 
plasmatic membrane did not lose integrity, similarly to apoptosis. 
In contrast, the necrotic/cell lysis inductor Triton X-100 produced 
a significant increase of extracellular LDH activity. (Figure 2L–M)
Xanthohumol and Quercetin Prevented CORT-
Induced Downregulation of Bdnf Gene Expression in 
Cortical Cells
Modulation of BDNF expression is one of the mechanisms 
through which neuroprotective agents exert their effects 
(Zhao et al., 2017). Thus, the effect of xanthohumol and quer-
cetin on CORT-induced reduction in mRNA Bdnf levels was in-
vestigated in cortical cells. After 96 hours of treatment, 200 µM 
CORT triggered a considerable reduction of Bdnf gene expression 
in cortical cells as previously reported (Pusceddu et  al., 2016). 
However, this Bdnf reduction was prevented by a pre-incubation 
with 5 µM xanthohumol and 3 µM quercetin for 24 hours (Figure 
2N–O). To investigate whether CORT-induced reduction of Bdnf 
expression is mediated by downregulation of Creb1, we first ex-
plored whether CORT regulates the Creb1 mRNA expression in 
cortical cells (Figure 2P–Q). Treatment with 200 µM CORT for 96 
hours did not induce changes in Creb1 expression in cortical 
cells. Moreover, neither 5 µM xanthohumol nor 3 µM quercetin 
was able to upregulate Creb1 gene expression. 
Inhibiting the Nrf2 Pathway Attenuated Only the 
Protective Effect of Xanthohumol Against Cort-
Induced Cytotoxicity in cortical cells
 The activation of Nrf2 pathway has been shown to be in-
volved in the protective mechanisms of polyphenols against 
CORT in neuronal models (Freitas et al., 2015; Sun et al., 2018). 
Thus we used a pharmacological approach to determine the 
mediatory role of the Nrf2 pathway in the protective effects of 
xanthohumol and quercetin against CORT-elicited cytotoxicity. 
We investigated whether trigonelline, an inhibitor of Nrf2 nu-
clear import (Arlt et al., 2013), could abolish the cytoprotective 
effect of these polyphenols against CORT-dependent reduc-
tion in cell viability in cortical cells. At DIV5 the cells received 
a treatment with both polyphenols and 5  µM trigonelline for 
24 hours and subsequently CORT stimulus for 96 hours (Figure 
3A). Trigonelline treatment ameliorated the increase in cell via-
bility induced by treatment with xanthohumol, which suggested 
that inhibition of the Nrf2 pathway blocked the protective effect 
of xanthohumol against CORT-induced cytotoxicity in cortical 
cells. In contrast, trigonelline did not affect the protective effects 
of quercetin against CORT-induced cytotoxicity (Figure 3B–C).
Xanthohumol Induced the Expression of Nrf2 Target 
Genes in Cortical Cells
We further investigated whether xanthohumol or quercetin 
induced the expression of Nrf2-driven cytoprotective/anti-
oxidant genes in cortical cells. At DIV5 the cells received 
a treatment with either xanthohumol or quercetin along 
with 5 µM trigonelline for 24 hours (Figure 3D). After 24-hour 
treatment with 5  µM xanthohumol, the mRNA expression 
of Nrf2-activated genes (Ho-1, Nqo-1, and Gclc) was signifi-
cantly increased. Moreover, 5  µM trigonelline co-treatment 
blocked xanthohumol-induced upregulation of Nrf2-activated 
genes, which confirmed the activation of Nrf2-pathway by 
xanthohumol (Figure 3E–G). On the other hand, 3 µM quercetin 
treatment did not induce expression of Nrf2-driven genes in 
cortical cells (Figure 3J–L).
Xanthohumol-Induced Bdnf Gene Expression Was  
Dependent of Nrf2 Activation
The effect of xanthohumol and quercetin on gene expres-
sion of Bdnf before CORT exposure was studied in cortical 
cells. Treatment with 5  µM xanthohumol for 24 hours re-
markably induced the gene expression of Bdnf and Creb1. 
Interestingly, 5  µM trigonelline prevented the increase in 
Bdnf and Creb1 gene expression induced by treatment with 
xanthohumol (Figure 3H–I). In contrast, 3 µM quercetin treat-
ment for 24 hours did not induce gene expression of Bdnf and 
Creb1 (Figure 3M–N). These data indicate that xanthohumol-
induced Creb1 and Bdnf gene expression may be mediated by 
the Nrf2 pathway.
Quercetin Enhanced FKBP5 Gene Expression After 
CORT Stimulus in Cortical Cells
Given that the Nrf2 pathway might not be involved in quercetin 
neuroprotection, we examined the GR signaling. The effect of 
xanthohumol and quercetin on GR-regulated gene expression 
after CORT treatment was studied in cortical cells. Although 
we did not find changes in Btg1, N3c1, and Sgk1 mRNA levels 
after CORT exposure, the gene expression of Fkbp5, Foxo3, and 
Gilz was significantly increased (Figure 4). Moreover, Fkbp5 ex-
pression was further  increased by pre-incubation with 3  µM 
quercetin followed by CORT treatment for 96 hours compared 
with CORT group alone (Figure 4H). Pre-treatment with 5  µM 
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Figure 2. Xanthohumol and quercetin prevented corticosterone (CORT)-induced changes in cortical cells. (A) Schematic representing the experiment timeline. (B–C) 
Cortical cells were pretreated with the indicated concentrations of xanthohumol and quercetin for 24 hours and then treated with 200 µM CORT for 96 hours. Cell via-
bility was measured by 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. (D–H) Quantitative analysis of neurons and astrocytes was per-
formed by immunostaining of βIII-tubulin+ and GFAP+ cells. Scale bar = 50 µm. (I–K) Cortical cells were pretreated with 5 µM xanthohumol or 3 µM quercetin for 24 hours 
and then exposed for 96 hours to 200 µM CORT. Morphological changes of the nuclei were determined by Hoechst 33258 staining. Scale bar = 50 µm. Red arrows indicate 
representative condensed nuclei. (L–M) Lactate dehydrogenase (LDH) activity was measured in cell culture media after polyphenol and CORT treatment. (N–Q) The gene 
expression was quantitatively measured using real time reverse transcription polymerase chain reaction (RT-PCR) for Bdnf and Creb1 mRNA relative expression. Results 
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CORT-Induced Changes in Akt/mTOR/AMPK 
Signaling Pathways
To investigate the impact of CORT treatment in signaling path-
ways associated with proliferation, cell growth, and apoptosis 
in cortical cells, we screened the activation or downregulation 
of proteins involved in these physiological processes using the 
RPPA approach. After treatment with 200 µM CORT for 96 hours, 
we found 46 proteins with altered expression (Figure 5A), and 
further analysis revealed that Akt, FOXO, mTOR, AMPK, and 
Neurotrophin signaling pathways were significantly affected 
Figure 3. Xanthohumol neuroprotection is mediated by the Nrf2 pathway. (A–C) Cortical cells were co-treated with 5  µM trigonelline and polyphe-
nols (5  µM xanthohumol or 3  µM quercetin) for 24 hours before 96-hour exposure to 200  µM corticosterone (CORT). Cell viability was detected by 
 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. (D) Cortical cells were co-treated with 5 µM trigonelline and 5 µM xanthohumol or 3 µM 
quercetin for 24 hours. Relative expression of  Nrf2-activated genes (Ho-1, Nqo-1, and Gclc), Creb1, and Bdnf induced by (E–I) xanthohumol and (J–N) quercetin was deter-
mined through real time reverse transcription polymerase chain reaction (RT-PCR). Data were expressed as the mean ± SEM of 3 independent experiments performed 
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(Figure 5B; KEGG codes: Akt map04151, FoxO map04068, mTOR 
map04150, AMPK map04152, and Neurotrophin map04722).
Impact of Xanthohumol and Quercetin on CORT-
Induced Changes in Akt/mTOR, AMPK, and Erk1/2 
Signaling Pathways
The effect of xanthohumol and quercetin on CORT-induced al-
teration in signaling pathways associated with proliferation and 
apoptosis was next investigated in cortical cells. Pre-incubation 
with xanthohumol or quercetin did not interfere significantly 
against CORT-induced changes in Akt, mTOR, and Erk1/2 signaling 
pathways (Figure 5D, F, G). Nevertheless, xanthohumol treatment 
prevented the increase of the pAMPK/AMPK ratio caused after 
CORT insult (Figure 5C). Surprisingly, xanthohumol abolished 
CORT-induced protein overexpression of connexin 43 (Cx43), 
which is not involved directly with these signaling pathways 
(Figure 5H).
Figure 4. Quercetin enhanced the expression of FK506 binding protein 5 (Fkbp5) after corticosterone (CORT) treatment in cortical cells. After 24-hour exposure to (A–F) 
5 µM xanthohumol or (G–L) 3 µM quercetin, cortical cells were treated for 96 hours with 200 µM CORT. The gene expression of Btg1, Fkbp5, Foxo3, Gilz, Nr3c1, and Sgk1 
was quantitatively measured using real time reverse transcription polymerase chain reaction (RT-PCR). Results are expressed as the mean ± SEM of 3 independent ex-
periments performed in triplicate (***P < .001; **P < .01; *P < .05 vs vehicle groups; #P < .05 vs CORT groups). Btg1, B-cell translocation gene 1; Foxo3, forkhead box O3; Gilz, 
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Figure 5. Impact of xanthohumol and quercetin on corticosterone (CORT)-induced changes in Akt/mTOR, AMPK, and Erk1/2 signaling pathways. (A) Schematic inter-
action map of proteins altered by CORT; upregulated expression of proteins is shown in green and downregulated proteins are highlighted in red. Cortical cells were 
treated with 200 µM CORT for 96 hours. The relative expression of proteins involved in proliferation, cell growth and apoptosis was determined using the reverse-phase 
protein array (RPPA) approach. (B) Kyoto encyclopedia of genes and genomes (KEGG) signaling pathways affected by CORT were detected using the functional anno-
tation tool DAVID 6.8. (C–H) After 24-hour exposure to 5 µM xanthohumol or 3 µM quercetin, cortical cells were treated for 96 hours with 200 µM CORT. The levels of 
protein expression of AMP-activated protein kinase (AMPK), protein kinase B (Akt), forkhead box O3 (FOXO3), mammalian target of rapamycin (mTOR), extracellular 
signal regulated kinase 1/2 (Erk1/2), and connexin 43 were quantitatively measured using RPPA and provided by MD Anderson. Results are expressed as the mean ± SEM 
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Discussion
In the present study, we demonstrated that administration of 
naturally derived polyphenols xanthohumol and quercetin sig-
nificantly protects primary cortical cells against CORT-elicited 
cytotoxicity, altered neuronal/astrocytic ratio, and reduced Bdnf 
expression. In addition, our results establish that trigonelline, 
an inhibitor of Nrf2, abolishes the neuroprotective effects of 
xanthohumol but not quercetin against CORT-induced cell 
death. Taken together, our findings reveal that although both 
xanthohumol and quercetin are neuroprotective agents, they 
recruit different cellular signaling pathways to induce such 
effects.
Several reports have demonstrated that the glucocorticoid 
hormone corticosterone exerts a toxic effect on neurons (Gao 
et al., 2015; Zhao et al., 2018). Additionally, increasing levels 
of CORT are associated with depressive and anxious-like be-
haviors in rodent models (Rosa et  al., 2014; Mendez-David 
et  al., 2017). Therefore, preventing the neurotoxic effects of 
glucocorticoids could represent a novel therapeutic approach 
for treatment of stress-related disorders. On the other hand, 
polyphenols have attracted considerable interest due to their 
multiple health benefits including antioxidant, anticancer, 
and neuroprotective effects (Vauzour et  al., 2010). However, 
the molecular mechanisms underlying polyphenol-mediated 
neuroprotection in neurons are not fully understood. Thus, 
the aim of the present study was to investigate whether the 
naturally derived polyphenolic compounds xanthohumol 
and quercetin prevent CORT-induced neurotoxicity in 
cortical cells.
Mixed cortical cell cultures containing both neurons and 
astrocytes have been extensively used as a model to study the 
neurotoxic effects of numerous stimulants in vitro (Wie et al., 
1997; Trackey et al., 2001; Huang et al., 2009). As expected, our 
data show that CORT treatment decreased the cell viability of 
cortical cells. In addition, further analysis indicated that CORT-
exerted cell death is mediated through activation of the GR, re-
sulting in the induction of apoptosis. In accordance with our 
findings, it has been shown before that CORT induces apoptosis 
via activation of the GR cascade in different neuronal models 
such as hippocampal neurons (Latt et  al., 2018), PC12 cells (Li 
et al., 2014), hypothalamic neurons (Zhang et al., 2012), and cor-
tical cells (Pusceddu et al., 2016).
We next demonstrated that treatment with xanthohumol 
and quercetin significantly reduced CORT-induced cytotox-
icity. In addition, these compounds reduced the alteration 
of cellular composition in cortical cells produced by CORT. 
Indeed, our study shows that the reduction in neuronal 
percentage and increased astrocytic concentration caused 
by CORT treatment are prevented by these polyphenols. In 
neural tissue, astrocytes play an important role in the regu-
lation of synapse, energy, and neurotransmitter balance 
(Sofroniew and Vinters, 2010). Accordingly, astrocytic over-
growth or astrogliosis has been described as a physiological 
process critical for neural protection and repair (Zhang et al., 
2007). This is in line with previous studies showing similar 
effects on astrocytes after CORT insult (Bridges et al., 2008; 
Pusceddu et al., 2016).
To further investigate the possible mechanisms underlying 
the protective effect of xanthohumol and quercetin against 
CORT-induced cytotoxicity, we examined the BDNF gene ex-
pression. BDNF is a neurotrophin involved in neuroplasticity 
and neuronal survival, which has been associated with 
neuroprotective effects in vitro and in vivo (Almeida et  al., 
2005; Motaghinejad et  al., 2017). Here we demonstrated that 
both polyphenols prevent CORT-induced reduction of Bdnf 
mRNA levels. Previous studies have demonstrated that sev-
eral polyphenols, including xanthohumol and quercetin, in-
duce the activation of Nrf2, which contributes significantly to 
cytoprotective and antioxidant responses in different cellular 
models (Tanigawa et al., 2007; Ungvari et al., 2010; Gopinath 
and Sudhandiran, 2012; Yao et  al., 2015). We found that 
trigonelline, an inhibitor of Nrf2, significantly reversed the 
protective effect of xanthohumol but not quercetin. Moreover, 
blocking Nrf2 activation abolished the xanthohumol-mediated 
increase of Bdnf mRNA levels, confirming previous studies that 
also highlight the crosstalk between BDNF and Nrf2 signaling 
(Mendez-David et al., 2015; Bouvier et al., 2017; Ishii and Mann, 
2018).
Surprisingly, quercetin treatment did not induce Bdnf gene 
expression, suggesting that quercetin prevented CORT-induced 
depletion of BDNF in cortical cells through an alternative mech-
anism. Interestingly, there is some evidence indicating that 
quercetin is able to activate Nrf2 signaling in other in vitro 
studies (Tanigawa et  al., 2007; Granado-Serrano et  al., 2012). 
However, the reason as to why quercetin fails to activate Nrf2 in 
cortical cells remains unknown.
To elucidate the mechanisms underlying the 
neuroprotection of quercetin, we examined whether quer-
cetin attenuates activation of the GR cascade following 
CORT stimulation. We hypothesized that downregulation 
of the GR signaling pathway could decrease CORT-induced 
cytotoxicity and eventually reverse BDNF depletion in cor-
tical cells. GR blockade strategies have been proposed to be 
a novel therapeutic approach to prevent the negative effects 
of chronic stress (Oomen et  al., 2007; Revsin et  al., 2009). 
In this regard, analysis of FKBP5, a protein that regulates 
GR sensitivity, is considered an interesting target for the 
prevention and treatment of stress-related psychiatric dis-
orders (Guidotti et  al., 2013). When FKBP5 is bound to the 
receptor complex, glucocorticoids bind with lower affinity 
and the nuclear translocation of the receptor is less effi-
cient (Binder, 2009). Our data demonstrate that quercetin 
treatment significantly increased expression of Fkbp5 after 
CORT stimuli in cortical cells, suggesting that the GR nega-
tive feedback system could be activated, thus preventing 
BDNF depletion.
BDNF-mediated neuroprotective mechanisms are associ-
ated with the activation of different molecular pathways re-
lated to proliferation and cell growth processes such as Akt, 
mTOR, and Erk1/2 (Han and Holtzman, 2000; Chen et al., 2013). 
Therefore, we analyzed components of these signaling path-
ways in cortical cells upon CORT stimulation. In this study, we 
established that CORT treatment significantly influences the 
proliferative pathways Akt and mTOR as well as metabolic 
signaling pathways that possibly trigger apoptosis, such as 
AMPK and FOXO3. Indeed, downregulation of Akt and mTOR 
is associated with decreased proliferation in neuronal models 
(Peltier et  al., 2007; Bhaskar et  al., 2009), while activation of 
AMPK/FOXO3 pathways indirectly lead to apoptotic signaling 
(Davila et al., 2012). Our results demonstrate that xanthohumol 
treatment reduced AMPK phosphorylation after CORT 
stimulus, indicating downregulation of this pathway. However, 
treatment with either xanthohumol or quercetin did not pre-
vent CORT-induced changes at protein levels of Akt, mTOR, and 
Erk1/2. These data suggest that activation of these proliferative 
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Additionally, we have demonstrated that xanthohumol signifi-
cantly blocked CORT-induced overexpression of Cx43 in cortical 
cells. The evidence suggests that Cx43 plays a proapoptotic role 
in different cytotoxic stimuli, which has been suggested before 
(Huang et al., 2001; Dong et al., 2015; Yahiro et al., 2015), although 
the mechanisms responsible for Cx43-mediated apoptosis are un-
known. Because Cx43 is the structural component of gap junctions 
and it is responsible for the transfer of water‐soluble molecules dir-
ectly from one cell to another without passing through the mem-
brane, the enhancement of cytotoxic effects on Cx43‐transfected 
cells may be due to increased transfer of drugs or proapoptotic 
molecules from one cell to another (Kameritsch et al., 2013).
In conclusion, our present work confirmed that naturally de-
rived polyphenols xanthohumol and quercetin attenuate CORT-
exerted neurotoxicity in primary cortical cultures. We further 
found that blocking the Nrf2 pathway could abolish the protective 
effect of xanthohumol, while quercetin neuroprotection may be 
mediated by FKBP5 modulation. Our data reveal that xanthohumol 
and quercetin mediate BDNF restoration upon CORT treatment in 
cortical cells, indicating the possible role of this neurotrophin in 
the neuroprotective mechanisms of these polyphenols. In add-
ition, our findings provide a novel insight into the mechanisms 
underlying polyphenol-mediated neuroprotective effects in vitro 
and potential health benefits for stress-related disorders.
Supplementary Materials
Supplementary data are available at International Journal of 
Neuropsychopharmacology (IJNPPY) online.
Acknowledgments
We thank Dr Matteo Pusceddu and Ms Loreto Olavarría for their 
assistance in performing the cell culture. 
The APC Microbiome Ireland has conducted research funded by 
many pharmaceutical and food companies. T.G.D. and J.F.C. have 
received research funding from Mead Johnson, Cremo, Suntory 
Wellness, Nutricia, 4D Pharma, and DuPont. This work was sup-
ported by Science Foundation Ireland (grant no. SFI/12/RC/2273) 
and the Department of Agriculture, Food and the Marine, Irish 
government (grant no. 13F 411).
Interest Statement
We declare no competing interests. However, in the interest of 
full disclosure, J.F.C. and T.G.D. have received research funding 
from Dupont Nutrition Biosciences APS, Cremo SA, Alkermes 
Inc., 4D Pharma PLC, Mead Johnson Nutrition, Nutricia Danone, 
and Suntory Wellness and have spoken at meetings sponsored 
by food and pharmaceutical companies.
References
Almeida  RD, Manadas  BJ, Melo  CV, Gomes  JR, Mendes  CS, 
Grãos  MM, Carvalho  RF, Carvalho  AP, Duarte  CB (2005) 
Neuroprotection by BDNF against glutamate-induced apop-
totic cell death is mediated by ERK and PI3-kinase pathways. 
Cell Death Differ 12:1329–1343.
Arlt A, Sebens S, Krebs S, Geismann C, Grossmann M, Kruse ML, 
Schreiber S, Schäfer H (2013) Inhibition of the Nrf2 transcrip-
tion factor by the alkaloid trigonelline renders pancreatic 
cancer cells more susceptible to apoptosis through decreased 
proteasomal gene expression and proteasome activity. Onco-
gene 32:4825–4835.
Arnsten  AF (2009) Stress signalling pathways that impair pre-
frontal cortex structure and function. Nat  Rev Neurosci 
10:410–422.
Arnsten  AF (2015) Stress weakens prefrontal networks: mo-
lecular insults to higher cognition. Nat  Neurosci 18:1376–
1385.
Bhaskar  K, Miller  M, Chludzinski  A, Herrup  K, Zagorski  M, 
Lamb  BT (2009) The PI3K-Akt-mTOR pathway regu-
lates Abeta oligomer induced neuronal cell cycle events. 
Mol Neurodegener 4:14.
Bhutada P, Mundhada Y, Bansod K, Ubgade A, Quazi M, Umathe S, 
Mundhada D (2010) Reversal by quercetin of corticotrophin 
releasing factor induced anxiety- and depression-like effect 
in mice. Prog Neuropsychopharmacol Biol Psychiatry 34:955–
960.
Binder EB (2009) The role of FKBP5, a co-chaperone of the gluco-
corticoid receptor in the pathogenesis and therapy of af-
fective and anxiety disorders. Psychoneuroendocrinology 34 
(Suppl 1):S186–S195.
Boots AW, Haenen GR, Bast A (2008) Health effects of quercetin: 
from antioxidant to nutraceutical. Eur J Pharmacol 585:325–
337.
Bouvier E, Brouillard F, Molet J, Claverie D, Cabungcal JH, Cresto N, 
Doligez  N, Rivat  C, Do  KQ, Bernard  C, Benoliel  JJ, Becker  C 
(2017) Nrf2-dependent persistent oxidative stress results in 
stress-induced vulnerability to depression. Mol  Psychiatry 
22:1701–1713.
Bridges N, Slais K, Syková E (2008) The effects of chronic cortico-
sterone on hippocampal astrocyte numbers: a comparison 
of male and female Wistar rats. Acta Neurobiol Exp (Wars) 
68:131–138.
Brito  PM, Mariano  A, Almeida  LM, Dinis  TC (2006) Resveratrol 
affords protection against peroxynitrite-mediated endothe-
lial cell death: a role for intracellular glutathione. Chem Biol 
Interact 164:157–166.
Brunoni AR, Lopes M, Fregni F (2008) A systematic review and 
meta-analysis of clinical studies on major depression and 
BDNF levels: implications for the role of neuroplasticity in 
depression. Int J Neuropsychopharmacol 11:1169–1180.
Chen A, Xiong LJ, Tong Y, Mao M (2013) Neuroprotective effect 
of brain-derived neurotrophic factor mediated by autophagy 
through the PI3K/Akt/mTOR pathway. Mol Med Rep 8:1011–
1016.
Davila  D, Connolly  NM, Bonner  H, Weisová  P, Dussmann  H, 
Concannon CG, Huber HJ, Prehn JH (2012) Two-step activation 
of FOXO3 by AMPK generates a coherent feed-forward loop 
determining excitotoxic cell fate. Cell Death Differ 19:1677–
1688.
de  Kloet  CS, Vermetten  E, Geuze  E, Kavelaars  A, Heijnen  CJ, 
Westenberg  HG (2006) Assessment of HPA-axis function in 
posttraumatic stress disorder: pharmacological and non-
pharmacological challenge tests, a review. J  Psychiatr Res 
40:550–567.
Dong  L, Yang  X, Gu  W, Zhao  K, Ge  H, Zhou  J, Bai  X (2015) 
Connexin 43 mediates PFOS-induced apoptosis in astrocytes. 
Chemosphere 132:8–16.
Freitas  AE, Egea  J, Buendía  I, Navarro  E, Rada  P, Cuadrado  A, 
Rodrigues  AL, López  MG (2015) Agmatine induces Nrf2 and 
protects against corticosterone effects in hippocampal neur-
onal cell line. Mol Neurobiol 51:1504–1519.
Gao S, Li W, Zou W, Zhang P, Tian Y, Xiao F, Gu H, Tang X (2015) 
H2S protects PC12 cells against toxicity of corticosterone by 







/ijnp/article-abstract/22/12/765/5669943 by Teagasc user on 09 January 2020
776 | International Journal of Neuropsychopharmacology, 2019
Godoy  JA, Lindsay  CB, Quintanilla  RA, Carvajal  FJ, Cerpa  W, 
Inestrosa  NC (2017) Quercetin exerts differential 
neuroprotective effects against H2O2 and Aβ aggre-
gates in hippocampal neurons: the role of mitochondria. 
Mol Neurobiol 54:7116–7128.
Gopinath K, Sudhandiran G (2012) Naringin modulates oxidative 
stress and inflammation in 3-nitropropionic acid-induced 
neurodegeneration through the activation of nuclear factor-
erythroid 2-related factor-2 signalling pathway. Neuroscience 
227:134–143.
Granado-Serrano  AB, Martín  MA, Bravo  L, Goya  L, Ramos  S 
(2012) Quercetin modulates Nrf2 and glutathione-related de-
fenses in HepG2 cells: involvement of p38. Chem Biol Interact 
195:154–164.
Guidotti  G, Calabrese  F, Anacker  C, Racagni  G, Pariante  CM, 
Riva MA (2013) Glucocorticoid receptor and FKBP5 expression 
is altered following exposure to chronic stress: modulation 
by antidepressant treatment. Neuropsychopharmacology 
38:616–627.
Hains  AB, Vu  MA, Maciejewski  PK, van  Dyck  CH, Gottron  M, 
Arnsten  AF (2009) Inhibition of protein kinase C signaling 
protects prefrontal cortex dendritic spines and cognition 
from the effects of chronic stress. Proc Natl Acad Sci U S A 
106:17957–17962.
Han BH, Holtzman DM (2000) BDNF protects the neonatal brain 
from hypoxic-ischemic injury in vivo via the ERK pathway. 
J Neurosci 20:5775–5781.
Huang  RP, Hossain  MZ, Huang  R, Gano  J, Fan  Y, Boynton  AL 
(2001) Connexin 43 (cx43) enhances chemotherapy-
induced apoptosis in human glioblastoma cells. Int  J 
Cancer 92:130–138.
Huang YN, Wu CH, Lin TC, Wang JY (2009) Methamphetamine in-
duces heme oxygenase-1 expression in cortical neurons and 
glia to prevent its toxicity. Toxicol Appl Pharmacol 240:315–
326.
Hurley LL, Akinfiresoye L, Kalejaiye O, Tizabi Y (2014) Antidepres-
sant effects of resveratrol in an animal model of depression. 
Behav Brain Res 268:1–7.
Ishii  T, Mann  GE (2018) When and how does brain-derived 
neurotrophic factor activate Nrf2 in astrocytes and neurons? 
Neural Regen Res 13:803–804.
Kameritsch P, Khandoga N, Pohl U, Pogoda K (2013) Gap junctional 
communication promotes apoptosis in a connexin-type-
dependent manner. Cell Death Dis 4:e584.
Latt HM, Matsushita H, Morino M, Koga Y, Michiue H, Nishiki T, 
Tomizawa K, Matsui H (2018) Oxytocin inhibits corticosterone-
induced apoptosis in primary hippocampal neurons. Neuro-
science 379:383–389.
Li ZY, Jiang YM, Liu YM, Guo Z, Shen SN, Liu XM, Pan RL (2014) 
Saikosaponin D acts against corticosterone-induced apop-
tosis via regulation of mitochondrial GR translocation and 
a GR-dependent pathway. Prog Neuropsychopharmacol Biol 
Psychiatry 53:80–89.
Liu M, Hansen PE, Wang G, Qiu L, Dong J, Yin H, Qian Z, Yang M, 
Miao  J (2015) Pharmacological profile of xanthohumol, a 
prenylated flavonoid from hops (Humulus lupulus). Mol-
ecules 20:754–779.
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expres-
sion data using real-time quantitative PCR and the 2(-Delta 
C(T)) method. Methods 25:402–408.
Lopresti AL, Maes M, Maker GL, Hood SD, Drummond PD (2014) 
Curcumin for the treatment of major depression: a random-
ised, double-blind, placebo controlled study. J  Affect Disord 
167:368–375.
Manach  C, Scalbert  A, Morand  C, Rémésy  C, Jiménez  L (2004) 
Polyphenols: food sources and bioavailability. Am J Clin Nutr 
79:727–747.
Mendez-David  I, Tritschler  L, Ali  ZE, Damiens  MH, Pallardy  M, 
David DJ, Kerdine-Römer S, Gardier AM (2015) Nrf2-signaling 
and BDNF: a new target for the antidepressant-like activity of 
chronic fluoxetine treatment in a mouse model of anxiety/
depression. Neurosci Lett 597:121–126.
Mendez-David  I, Boursier  C, Domergue  V, Colle  R, Falissard  B, 
Corruble E, Gardier AM, Guilloux JP, David DJ (2017) Differen-
tial peripheral proteomic biosignature of fluoxetine response 
in a mouse model of anxiety/depression. Front Cell Neurosci 
11:237.
Mitra R, Sapolsky RM (2008) Acute corticosterone treatment is 
sufficient to induce anxiety and amygdaloid dendritic hyper-
trophy. Proc Natl Acad Sci U S A 105:5573–5578.
Mosmann T (1983) Rapid colorimetric assay for cellular growth 
and survival: application to proliferation and cytotoxicity as-
says. J Immunol Methods 65:55–63.
Motaghinejad M, Motevalian M, Fatima S, Hashemi H, Gholami M 
(2017) Curcumin confers neuroprotection against alcohol-
induced hippocampal neurodegeneration via CREB-BDNF 
pathway in rats. Biomed Pharmacother 87:721–740.
Murakami S, Imbe H, Morikawa Y, Kubo C, Senba E (2005) Chronic 
stress, as well as acute stress, reduces BDNF mRNA expres-
sion in the rat hippocampus but less robustly. Neurosci Res 
53:129–139.
O’Leary  JC 3rd, Zhang  B, Koren  J 3rd, Blair  L, Dickey  CA (2013) 
The role of FKBP5 in mood disorders: action of FKBP5 on 
steroid hormone receptors leads to questions about its 
evolutionary importance. CNS Neurol Disord Drug Targets 
12:1157–1162.
Oomen  CA, Mayer  JL, de  Kloet  ER, Joëls  M, Lucassen  PJ (2007) 
Brief treatment with the glucocorticoid receptor antagonist 
mifepristone normalizes the reduction in neurogenesis after 
chronic stress. Eur J Neurosci 26:3395–3401.
Pariante  CM, Lightman  SL (2008) The HPA axis in major de-
pression: classical theories and new developments. Trends 
Neurosci 31:464–468.
Peltier J, O’Neill A, Schaffer DV (2007) PI3K/Akt and CREB regulate 
adult neural hippocampal progenitor proliferation and differ-
entiation. Dev Neurobiol 67:1348–1361.
Pusceddu MM, Nolan YM, Green HF, Robertson RC, Stanton C, 
Kelly  P, Cryan  JF, Dinan  TG (2016) The Omega-3 polyun-
saturated fatty acid docosahexaenoic acid (DHA) reverses 
corticosterone-induced changes in cortical neurons. 
Int  J Neuropsychopharmacol 19:pyv130. doi:10.1093/ijnp/
pyv130.
Revsin  Y, Rekers  NV, Louwe  MC, Saravia  FE, De  Nicola  AF, 
de Kloet ER, Oitzl MS (2009) Glucocorticoid receptor blockade 
normalizes hippocampal alterations and cognitive im-
pairment in streptozotocin-induced type 1 diabetes mice. 
Neuropsychopharmacology 34:747–758.
Rizza S, Cirotti C, Montagna C, Cardaci S, Consales C, Cozzolino M, 
Carrì  MT, Cecconi  F, Filomeni  G (2015) S-Nitrosoglutathione 
reductase plays opposite roles in SH-SY5Y models of 
Parkinson’s disease and amyotrophic lateral sclerosis. Medi-
ators Inflamm 2015:536238.
Rosa PB, Ribeiro CM, Bettio LE, Colla A, Lieberknecht V, Moretti M, 
Rodrigues  AL (2014) Folic acid prevents depressive-like be-
havior induced by chronic corticosterone treatment in mice. 
Pharmacol Biochem Behav 127:1–6.
Sapolsky RM (2000) Glucocorticoids and hippocampal atrophy in 






/ijnp/article-abstract/22/12/765/5669943 by Teagasc user on 09 January 2020
Donoso et al. | 777
Shansky  RM, Hamo  C, Hof  PR, McEwen  BS, Morrison  JH (2009) 
Stress-induced dendritic remodeling in the prefrontal cortex 
is circuit specific. Cereb Cortex 19:2479–2484.
Sofroniew MV, Vinters HV (2010) Astrocytes: biology and path-
ology. Acta Neuropathol 119:7–35.
Spencer JP (2008) Food for thought: the role of dietary flavonoids 
in enhancing human memory, learning and neuro-cognitive 
performance. Proc Nutr Soc 67:238–252.
Sun  Q, Jia  N, Yang  J, Chen  G (2018) Nrf2 signaling pathway 
mediates the antioxidative effects of taurine against 
corticosterone-induced cell death in HUMAN SK-N-SH cells. 
Neurochem Res 43:276–286.
Tanigawa S, Fujii M, Hou DX (2007) Action of Nrf2 and Keap1 in 
ARE-mediated NQO1 expression by quercetin. Free Radic Biol 
Med 42:1690–1703.
Trackey  JL, Uliasz  TF, Hewett  SJ (2001) SIN-1-induced cytotox-
icity in mixed cortical cell culture: peroxynitrite-dependent 
and -independent induction of excitotoxic cell death. 
J Neurochem 79:445–455.
Ungvari Z, Bagi Z, Feher A, Recchia FA, Sonntag WE, Pearson K, 
de  Cabo  R, Csiszar  A (2010) Resveratrol confers endothelial 
protection via activation of the antioxidant transcription 
factor Nrf2. Am J Physiol Heart Circ Physiol 299:H18–H24.
Vauzour  D (2012) Dietary polyphenols as modulators of brain 
functions: biological actions and molecular mechanisms 
underpinning their beneficial effects. Oxid Med Cell Longev 
2012:914273.
Vauzour  D, Rodriguez-Mateos  A, Corona  G, Oruna-Concha  MJ, 
Spencer JP (2010) Polyphenols and human health: prevention 
of disease and mechanisms of action. Nutrients 2:1106–1131.
Wei K, Xu Y, Zhao Z, Wu X, Du Y, Sun J, Yi T, Dong J, Liu B (2016) 
Icariin alters the expression of glucocorticoid receptor, FKBP5 
and SGK1 in rat brains following exposure to chronic mild 
stress. Int J Mol Med 38:337–344.
Wie  MB, Won  MH, Lee  KH, Shin  JH, Lee  JC, Suh  HW, Song  DK, 
Kim  YH (1997) Eugenol protects neuronal cells from 
excitotoxic and oxidative injury in primary cortical cultures. 
Neurosci Lett 225:93–96.
Yahiro K, Akazawa Y, Nakano M, Suzuki H, Hisatune J, Isomoto H, 
Sap J, Noda M, Moss J, Hirayama T (2015) Helicobacter pylori 
VacA induces apoptosis by accumulation of connexin 43 in 
autophagic vesicles via a Rac1/ERK-dependent pathway. Cell 
Death Discov 1:15035.
Yao J, Zhang B, Ge C, Peng S, Fang J (2015) Xanthohumol, a poly-
phenol chalcone present in hops, activating Nrf2 enzymes 
to confer protection against oxidative damage in PC12 cells. 
J Agric Food Chem 63:1521–1531.
Zhang H, Liu B, Wu J, Xu C, Tao J, Duan X, Cao Y, Dong J (2012) 
Icariin inhibits corticosterone-induced apoptosis in hypo-
thalamic neurons via the PI3-K/Akt signaling pathway. 
Mol Med Rep 6:967–972.
Zhang L, Zhang WP, Chen KD, Qian XD, Fang SH, Wei EQ (2007) 
Caffeic acid attenuates neuronal damage, astrogliosis and 
glial scar formation in mouse brain with cryoinjury. Life Sci 
80:530–537.
Zhao H, Alam A, San CY, Eguchi S, Chen Q, Lian Q, Ma D (2017) Mo-
lecular mechanisms of brain-derived neurotrophic factor in 
neuro-protection: recent developments. Brain Res 1665:1–21.
Zhao X, Li R, Jin H, Jin H, Wang Y, Zhang W, Wang H, Chen W 
(2018) Epigallocatechin-3-gallate confers protection against 
corticosterone-induced neuron injuries via restoring extra-
cellular signal-regulated kinase ½ and phosphatidylinositol-3 
kinase/protein kinase B signaling pathways. Plos One 
13:e0192083.
Zhu H, Zhao Z, Zhou Y, Chen X, Li Y, Liu X, Lu H, Zhang Y, Zhang J 
(2013) High-dose glucocorticoid aggravates TBI-associated cor-
ticosteroid insufficiency by inducing hypothalamic neuronal 






/ijnp/article-abstract/22/12/765/5669943 by Teagasc user on 09 January 2020
